| CEACAM1 regulates TIM-3-mediated tolerance and exhaustion YH Huang, C Zhu, Y Kondo, AC Anderson, A Gandhi, A Russell, ... Nature 517 (7534), 386-390, 2015 | 638 | 2015 |
| HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation U Feger, E Tolosa, YH Huang, A Waschbisch, T Biedermann, A Melms, ... Blood, The Journal of the American Society of Hematology 110 (2), 568-577, 2007 | 245 | 2007 |
| Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells Finnish Multiple Sclerosis and Pregnancy Study Group Airas L laura. airas ... Clinical & Experimental Immunology 151 (2), 235-243, 2008 | 134 | 2008 |
| T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible YH Huang, AL Zozulya, C Weidenfeller, N Schwab, H Wiendl Journal of leukocyte biology 86 (2), 273-281, 2009 | 107 | 2009 |
| CEACAM1 as a multi-purpose target for cancer immunotherapy M Dankner, SD Gray-Owen, YH Huang, RS Blumberg, N Beauchemin Oncoimmunology 6 (7), e1328336, 2017 | 106 | 2017 |
| Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy CA Sabatos-Peyton, J Nevin, A Brock, JD Venable, DJ Tan, N Kassam, ... Oncoimmunology 7 (2), e1385690, 2018 | 104 | 2018 |
| Specific central nervous system recruitment of HLA‐G+ regulatory T cells in multiple sclerosis YH Huang, AL Zozulya, C Weidenfeller, I Metz, D Buck, KV Toyka, ... Annals of Neurology: Official Journal of the American Neurological …, 2009 | 85 | 2009 |
| CEACAM1 dampens antitumor immunity by down-regulating NKG2D ligand expression on tumor cells Z Chen, L Chen, K Baker, T Olszak, S Zeissig, YH Huang, TT Kuo, ... Journal of Experimental Medicine 208 (13), 2633-2640, 2011 | 74 | 2011 |
| CEACAM1 structure and function in immunity and its therapeutic implications WM Kim, YH Huang, A Gandhi, RS Blumberg Seminars in immunology 42, 101296, 2019 | 71 | 2019 |
| Neutrophil extracellular trap–associated CEACAM1 as a putative therapeutic target to prevent metastatic progression of colon carcinoma RF Rayes, P Vourtzoumis, M Bou Rjeily, R Seth, F Bourdeau, B Giannias, ... The Journal of Immunology 204 (8), 2285-2294, 2020 | 63 | 2020 |
| The role of leukemia-derived B7-H1 (PD-L1) in tumor–T-cell interactions in humans HR Salih, S Wintterle, M Krusch, A Kroner, YH Huang, L Chen, H Wiendl Experimental hematology 34 (7), 888-894, 2006 | 60 | 2006 |
| CEACAM 1 on activated NK cells inhibits NKG 2 D‐mediated cytolytic function and signaling S Hosomi, Z Chen, K Baker, L Chen, YH Huang, T Olszak, S Zeissig, ... European journal of immunology 43 (9), 2473-2483, 2013 | 54 | 2013 |
| Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G L Airas, T Nikula, YH Huang, R Lahesmaa, H Wiendl Journal of neuroimmunology 187 (1-2), 205-211, 2007 | 52 | 2007 |
| The short isoform of the CEACAM1 receptor in intestinal T cells regulates mucosal immunity and homeostasis via Tfh cell induction L Chen, Z Chen, K Baker, EM Halvorsen, AP da Cunha, MB Flak, ... Immunity 37 (5), 930-946, 2012 | 47 | 2012 |
| Correction: Corrigendum: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion YH Huang, C Zhu, Y Kondo, AC Anderson, A Gandhi, A Russell, ... Nature 536 (7616), 359-359, 2016 | 39 | 2016 |
| High resolution X-ray and NMR structural study of human T-cell immunoglobulin and mucin domain containing protein-3 AK Gandhi, WM Kim, ZYJ Sun, YH Huang, DA Bonsor, EJ Sundberg, ... Scientific Reports 8 (1), 17512, 2018 | 36 | 2018 |
| Finnish Multiple Sclerosis and Pregnancy Study Group. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells L Airas, M Saraste, S Rinta, I Elovaara, YH Huang, H Wiendl Clin Exp Immunol 151 (2), 235-243, 2008 | 35 | 2008 |
| New insights into the regulation of natural-killer group 2 member D (NKG2D) and NKG2D-ligands: endoplasmic reticulum stress and CEA-related cell adhesion molecule 1 S Hosomi, J Grootjans, YH Huang, A Kaser, RS Blumberg Frontiers in immunology 9, 1324, 2018 | 25 | 2018 |
| Anti-CEACAM1 recombinant antibodies for cancer therapy RS Blumberg, YH Huang, N Utku US Patent 9,556,271, 2017 | 25 | 2017 |
| Fatal progressive multifocal leukoencephalopathy associated with efalizumab therapy: Insights into the role of leukointegrin alpha L beta 2 in JC virus control N Schwab, JC Ulzheimer, RJ Fox, YH Huang, T Schneider-Hohendorf, ... Sage Publications Ltd, 2009 | 16 | 2009 |
